Total Payments
$5,321
2024 Payments
$776.13
Companies
48
Transactions
344
Medicare Patients
738
Medicare Billing
$21,130
Payment Breakdown by Category
Food & Beverage$5,088 (95.6%)
Education$232.64 (4.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,088 | 336 | 95.6% |
| Education | $232.64 | 8 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $824.44 | 48 | $0 (2024) |
| PFIZER INC. | $689.90 | 51 | $0 (2024) |
| ABBVIE INC. | $562.79 | 34 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $399.68 | 26 | $0 (2024) |
| MAYNE PHARMA COMMERCIAL LLC | $294.65 | 18 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $254.55 | 18 | $0 (2024) |
| Exeltis, USA Inc. | $188.91 | 14 | $0 (2024) |
| Mylan Pharmaceuticals Inc. | $163.32 | 12 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $139.94 | 9 | $0 (2021) |
| Duchesnay USA Incorporated | $137.60 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $776.13 | 47 | MAYNE PHARMA COMMERCIAL LLC ($228.37) |
| 2023 | $806.87 | 48 | PFIZER INC. ($180.63) |
| 2022 | $665.09 | 43 | PFIZER INC. ($85.51) |
| 2021 | $720.33 | 49 | AbbVie Inc. ($259.76) |
| 2020 | $389.10 | 25 | Astellas Pharma US Inc ($106.20) |
| 2019 | $621.07 | 40 | Astellas Pharma US Inc ($134.31) |
| 2018 | $662.14 | 42 | Astellas Pharma US Inc ($141.51) |
| 2017 | $680.06 | 50 | PFIZER INC. ($167.30) |
All Payment Transactions
344 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Hematology | ||||||
| 12/12/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $28.34 | General |
| 12/12/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $2.78 | General |
| 12/03/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: HORMONE THERAPY | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Womens Health | ||||||
| 11/14/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: CONTRACEPTIVE | ||||||
| 11/12/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $25.04 | General |
| 11/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: UROLOGY | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: HORMONE THERAPY | ||||||
| 10/29/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/18/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $8.91 | General |
| 10/08/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: HORMONE THERAPY | ||||||
| 10/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Biological | ||||||
| 09/30/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $23.62 | General |
| 09/30/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $1.86 | General |
| 09/20/2024 | Northgate Technologies, Inc. | Stimsite (Device) | Food and Beverage | Cash or cash equivalent | $24.12 | General |
| Category: General Surgery | ||||||
| 09/20/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: HORMONE THERAPY | ||||||
| 09/20/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $1.01 | General |
| Category: HORMONE THERAPY | ||||||
| 09/06/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $24.88 | General |
| 09/06/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $2.54 | General |
| 08/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Biological | ||||||
| 08/08/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: HORMONE THERAPY | ||||||
| 07/22/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $20.98 | General |
| 06/24/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $14.05 | General |
| 06/24/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $1.86 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 135 | 159 | $8,315 | $4,377 |
| 2022 | 5 | 103 | 105 | $4,763 | $3,237 |
| 2021 | 8 | 259 | 9,724 | $12,932 | $7,358 |
| 2020 | 8 | 241 | 9,924 | $12,229 | $6,158 |
Total Patients
738
Total Services
19,912
Medicare Billing
$21,130
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 58 | 58 | $2,320 | $2,067 | 89.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 20 | $3,080 | $1,299 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $1,740 | $698.20 | 40.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 25 | $900.00 | $226.27 | 25.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 15 | 15 | $150.00 | $59.10 | 39.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 25 | $125.00 | $27.80 | 22.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 41 | 41 | $1,640 | $1,519 | 92.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 21 | $2,247 | $1,104 | 49.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 12 | 12 | $600.00 | $484.48 | 80.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 17 | 17 | $136.00 | $74.26 | 54.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 13 | 14 | $140.00 | $55.44 | 39.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 73 | 73 | $2,920 | $2,712 | 92.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 31 | $3,255 | $1,801 | 55.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 34 | 34 | $1,700 | $1,378 | 81.1% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 14 | 14 | $1,670 | $492.80 | 29.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 54 | $1,944 | $449.40 | 23.1% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 65 | 65 | $520.00 | $284.70 | 54.8% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2021 | 14 | 9,400 | $658.00 | $174.32 | 26.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 15 | 53 | $265.00 | $65.67 | 24.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 65 | 65 | $2,695 | $2,428 | 90.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 26 | $2,730 | $1,145 | 41.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 28 | 28 | $1,400 | $1,115 | 79.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 18 | 65 | $2,340 | $517.54 | 22.1% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 12 | 12 | $1,560 | $432.56 | 27.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2020 | 64 | 64 | $512.00 | $278.61 | 54.4% |
About Dr. Patton Morrisonbarton, M.D
Dr. Patton Morrisonbarton, M.D is a Obstetrics & Gynecology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275560211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patton Morrisonbarton, M.D has received a total of $5,321 in payments from pharmaceutical and medical device companies, with $776.13 received in 2024. These payments were reported across 344 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($5,088).
As a Medicare-enrolled provider, Morrisonbarton has provided services to 738 Medicare beneficiaries, totaling 19,912 services with total Medicare billing of $21,130. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Specialist
- Location Mobile, AL
- Active Since 06/26/2006
- Last Updated 08/10/2010
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1275560211
Products in Payments
- PREMARIN (Drug) $490.68
- MYRBETRIQ (Drug) $395.06
- Kyleena (Drug) $344.79
- LO LOESTRIN FE (Drug) $333.77
- MYFEMBREE (Drug) $314.08
- Myrbetriq (Drug) $178.13
- Xulane (Drug) $148.24
- NASCOBAL (Drug) $139.94
- Orilissa (Drug) $134.31
- ACCRUFER (Drug) $133.37
- SLYND (Drug) $129.95
- INTRAROSA (Drug) $109.93
- Veozah (Drug) $108.88
- Osphena (Drug) $108.08
- PREMARIN ORALS (Drug) $103.03
- PVC (Drug) $79.46
- ANNOVERA (Drug) $77.64
- NEXPLANON (Drug) $73.22
- Paragard (Device) $57.28
- Mirena (Drug) $54.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Mobile
Timothy Hughes, M.d, M.D
Obstetrics & Gynecology — Payments: $131,684
Obstetrics & Gynecology $131,684
Dr. Phillip Madonia, M.d, M.D
Obstetrics & Gynecology — Payments: $61,287
Obstetrics & Gynecology $61,287
Nathaniel Jones, Md, MD
Obstetrics & Gynecology — Payments: $16,004
Obstetrics & Gynecology $16,004
Dr. Quin Bixler, M.d, M.D
Obstetrics & Gynecology — Payments: $12,028
Obstetrics & Gynecology $12,028
Craig Sherman, Md, MD
Obstetrics & Gynecology — Payments: $8,276
Obstetrics & Gynecology $8,276
Dr. Margaret Krueger, D.o, D.O
Obstetrics & Gynecology — Payments: $8,226
Obstetrics & Gynecology $8,226